Latest
Long Noncoding RNA Profiling May Be Effective for Stratification in Pediatric AML
FDA Panel in Favor of Paxlovid for COVID-19 Treatment
A Comparison of Therapeutic vs Prophylactic Anticoagulation in COVID-19
Race, Ethnicity Reporting in Pediatric Clinical Trials Has Improved
No Advantage Seen With Low-Titer Group O Whole Blood Over Component Therapy in Emergency Transfusion
Adding Ibrutinib to RICE or RVICI Provides No Benefit in Pediatric Rel/Ref B-NHL
Anti-GPRC5D CAR-T Therapy Elicits Responses After Anti-BCMA CAR Failure
Achieving, Managing Patient Care During Maintenance Therapy for AML
Acute Care Use Increased for Cancer Patients With Higher Symptom Complexity
Leniolisib Improves Immune Dysfunction in Activated PI3Kδ Syndrome
Study Reveals “Suboptimal” MIPS Participation Among Oncologists
Radical Cystectomy Increases Risks for Thromboembolic Events
Featured Content
Ponatinib Linked With Better Outcomes Than Imatinib in Philadelphia Chromosome-Positive ALL
The phase 3 PhALLCON trial showed a trend toward improved EFS in patients with Ph+ newly diagnosed ALL when treated with ponatinib compared with imatinib.
Peer Support Essential for Young Adults Recovering From Cancer Treatment
A review of the importance family, friends, and a support system have on the cancer journey and survival outcomes for young adults with cancer.
EAHAD 2023: Treatments Show Promise for Hemophilia A and B
At EAHAD 2023, researchers reported positive results from trials of patients with hemophilia A and B, including those who are difficult to treat.
Cancer Patients May Fall Prey to Illegitimate Online Pharmacies
High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.
- Loading...
Loading...
Loading... 
Loading...